A Patient-Centric Platform Trial for Precision Oncology

Research Study on Cancer Treatment Decisions and Outcomes

Recruiting
All
Phase N/A
10000 participants needed
1 Location

Study Overview

XCELSIOR is a non-interventional data registry. Information about treatments, treatment decisions and rationale, and patient outcomes including safety and effectiveness of anti-cancer therapy and associated supportive care will be collected for analysis.

Study Details

XCELSIOR is patient-centric study for the registration of cancer patients, operations of a virtual tumor board, insight capture in clinical decision making, and collection of longitudinal, observational data in a cancer registry. Patient intake into XCELSIOR will occur through the Cancer Commons Web portal. This includes consent to participate in the data registry, including the collection and review of medical information by a Virtual Tumor Board, generation of patient-specific treatment options with supporting rationale, access to treatment access support services, and inclusion into a registry study that includes safety and efficacy outcomes tracking. Patients will be treated and tracked in their original treatment setting and the data generated will form part of a systematic framework combining expert judgment with artificial intelligence to maximize information gain and improve treatment option set development for individual cancer patients.

Eligibility Criteria

You may be eligible for this study if you meet the following criteria:

  • Conditions: Oncology
  • Gender: All

Inclusion Criteria:
  • Both male and female patients with known or suspected recalcitrant or advanced cancer are eligible to enroll through the Cancer Commons Website
  • Patients with any performance status, comorbidity or disease severity are eligible
  • Patients or their legally-authorized representative must be willing and able to provide written, informed consent (and assent, if applicable)
Exclusion Criteria:
  • Patients must be a resident of or receiving care within the United States or US territories.

Updated on 03 Dec 2024. Study ID: NCT03793088

This study investigates the collection of data on cancer treatments and patient outcomes. The purpose is to understand the safety and effectiveness of anti-cancer therapies and the decisions made during treatment. This study involves a registry where information is gathered from cancer patients to analyze treatment decisions and their outcomes.

Participants will have their medical information reviewed by a Virtual Tumor Board, which will help generate personalized treatment options. The data collected will be used to track the safety and effectiveness of treatments over time, and will contribute to a framework that combines expert judgment with artificial intelligence to develop better treatment options for cancer patients.

  • Who can participate: Adults with known or suspected advanced cancer, regardless of performance status, comorbidity, or disease severity, can join the study through the Cancer Commons Website. Participants must be able to provide written consent and be residents of the United States or its territories.
  • Study details: Participants will provide consent to have their medical information collected and reviewed by a Virtual Tumor Board. The study will include tracking of treatment safety and effectiveness. Participants will remain in their original treatment settings while data is collected.

Find a study site near you

We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Other language